Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3214 results found
Expand All
Apply All
3214 results found

BIO Letter of Support for SECURE Data Act
Share
Letters, Testimony & Comments  •  June 4, 2026

Accelerating Scientific Breakthroughs With AI
Share
Webinars  •  June 4, 2026
Elevate your research with Google Cloud AI solutions for Healthcare and Life Sciences, designed to help your organization supercharge scientific breakthroughs. Join our upcoming webinar to discover how AI is helping to transform the laboratory landscape by automating the most time-consuming parts of the research cycle. From rapid hypothesis generation and intelligent experimental design to complex multi-modal data analysis, Google Cloud solutions like Co-Scientist, Alpha Genome, and Alpha Evolve can act as a force multiplier for your team. Learn how to: Accelerate Discovery: Shorten the path from inquiry to impact with automated literature synthesis and real-time reasoning. Optimize Workflows: Streamline lab operations and simulate experimental outcomes before picking up a pipette. Unlock Innovation: Uncover hidden patterns in your data that traditional methods often miss. Whether you’re in drug discovery, materials science, or academic research, this webinar will show you how to merge human expertise with AI precision to stay at the forefront of innovation. Don’t miss the chance to see the future of science in action.
Read More
AI innovative research image

Reshoring Biotech to the United States: Why Puerto Rico Leads the Way
Share
Webinars  •  June 3, 2026
As life sciences companies rethink global supply chains, reshoring has become a strategic priority. But where in the U.S. can companies scale efficiently, access skilled talent, and remain cost-competitive?This panel explores why Puerto Rico stands out as a proven and future-ready destination for bioscience investment. Hear directly from industry leaders who have established or expanded operations on the island, and gain insights into manufacturing capabilities, incentives, and the broader innovation ecosystem.If you’re evaluating U.S. expansion, this conversation will provide a clear perspective on why Puerto Rico isn’t just part of the equation; it’s a strategic advantage.
Read More
Made in Puerto Rico image2

The Future is Brighter When Your Team Has the Right Mix
Share

Global Out-Licensing Considerations for Manufacturers
Share
Webinars  •  June 2, 2026
The biopharmaceutical ecosystem is facing heightened uncertainty, driven by funding constraints, regulatory shifts, and policy reforms—including pricing pressures and the potential expansion of international reference pricing. These dynamics are reshaping dealmaking and raising critical questions for companies pursuing global out‑licensing strategies.Join experts from Covington for a timely discussion on how these trends are influencing licensing decisions, with insights on:Structuring Out‑Licensing Agreements and Territory Splits – strategic and practical considerationsPolicy Impacts on Licensing – Key developments in the U.S. and EUExecuting Near‑Term Deals – practical guidance in an evolving market++++++++++++++++++++++ This program is accredited for CLE in CA and NY (for both newly admitted and experienced attorneys). Credit will be applied as requested but cannot be guaranteed for VA or WA. The following jurisdictions may accept reciprocal credit: AZ, AR, CT, NJ, and HI. A general certificate of attendance and necessary materials will be provided for all other jurisdictions to support self-application. To receive CLE credit, attendees must complete the CLE Attendance Verification Form within 5 business days of the program. This form must be submitted after the program using the verification code shared during the session. ++++++++++++++++++++++
Read More
Global Pharma Manufacturing image

BIO 2026 First Time Attendee Webinar
Share
Webinars  •  May 28, 2026
Is this the first time you’re attending BIO International Convention? This webinar is for you! You’ll get insider tips from the BIO team on how to maximize your time at BIO 2026 and learn what’s new this year at the largest event for biotechnology in the world. If you haven't already registered for BIO 2026, you can find more information on the BIO International Convention website.
Read More
First Timer Attendee Bash image

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in Virginia
Share
Press Release  •  May 22, 2026
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia:“BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 -- legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor's action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy."BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector."We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”###
Read More

James Roe's journey: Racing with athsma
Share
Bio.News  •  May 18, 2026
James Roe bringing his asthma story to BIO 2026. Plus Women's Health Month. (1,030 words, 3 minutes, 58 seconds)
Read More

BIO Statement on Resignation of FDA Commissioner Marty Makary
Share
Press Release  •  May 12, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE changes, which included the firing of thousands of employees. These staffing and morale challenges were compounded by constant leadership changes over the past year and questions around shifting FDA standards for drug approvals. What we need now is strong, stable and science-driven leadership at the FDA. We are losing the biotech race with China. FDA must be strengthened immediately to ensure that patients continue to benefit from medical miracles and that the United States leads the world in biomedical innovation, which is crucial for the public health, economic growth and our national security.”  ###
Read More

Inside biotech dealmaking
Share
Bio.News  •  May 11, 2026
How to make the most of partnering at BIO 2026. Plus our explainer on PDUFA. (719 words, 2 minutes, 53 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 10
  • 11
  • 12
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO